G

GlycoMimetics

D
GLYC
USD
0.0444
(11.84%)
Market Closed
67,162.00
Volume
-0.5
EPS
-
Div Yield
-0.666667
P/E
27,044,571.99
Market Cap
Today
11.8400%
1 Week
4.771%
1 Month
173.047%
6 Months
37.148%
12 Months
-68.701%
Year To Date
-82.229%
All Time
0%

Title:
GlycoMimetics

Sector:
Healthcare
Industry:
Biotechnology
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Do you need help or have a question?